Study Information

Alliance Study ID: NCCTG-N99C4

NCT Study ID (ClinicalTrials.gov): NCT00033592

Disease or Cancer Type: Lung Cancer & Mesothelioma

Alliance Study Chair: Richard D. Hurt, MD

Status: COMPLETED


Study Description

RATIONALE: Use of a nicotine inhaler and/or bupropion may be effective in helping people stop smoking and prevent them from starting smoking again. It is not yet known whether a nicotine inhaler or bupropion are more effective alone or combined for stopping smoking.

PURPOSE: Randomized phase III trial to compare the effectiveness of the nicotine inhaler or bupropion alone to that of the nicotine inhaler combined with bupropion in helping people to stop smoking and prevent starting smoking again.

Related Publications

For publications related to this and other clinical trials, visit the Alliance Publications Application.

Data Sources & Contacts

Related Alliance Trials